News & Articles

Combining urine strip reading and digital microscopy, the LAURA XL delivers fully automated processing of urine samples

Designed specifically for smaller biobanks the BB package simplifies sample integrity, tracking and audit trail.

Cobas 6800/8800 system can be used to test for EBV and BKV in transplant patients

We celebrate the clinical laboratory products that have made the most difference to your lab work or point-of-care testing and reveal our most popular clinical content of the year

Download the microbiome workflow poster from Eppendorf

Researchers take first step to understanding of the potential impact of the microbiome on amyotrophic lateral sclerosis

Drop by and see SelectScience on booth #724 at this year's AACC conference in Anaheim, California, from August 4-8

From rare pathogens to pandemic prevention, explore the latest techniques and technologies that are shaping today’s diagnosis and treatment of infectious diseases

Help us celebrate the best new clinical assays, kits, instruments and devices by casting your vote today

TTP enables development of MosaiQ™ diagnostic platform for transfusion typing and disease screening

Three Fraunhofer Institutes will jointly present selected laboratory and biotechnology topics at LABVOLUTION 2019

New system promises to deliver antibiotic susceptibility testing results in two hours to help avoid misuse of antibiotics in suspected sepsis patients

The Unyvero Platform allows rapid testing for a broad range of pathogens and antibiotic resistance markers associated with life-threatening infections in hospitalized patients

UK researchers hope rapid Actiphage® test could improve TB screening

DiaSorin Molecular receives FDA clearance for Bordetella test

New molecular assay enables rapid antibiotic resistance result to support use of cost effective and convenient oral antibiotic for gonorrhea treatment

Simplexa™ GBS Direct molecular assay enables in vitro detection of Group B Streptococcus

Fully-automated BD Phoenix™ CPO Detect Test Receives U.S. FDA Clearance

Bacteria that were thought to be resistant to a powerful antibiotic may be susceptible to treatment after all, research has found

A celebration of the clinical laboratory products that have made the most difference to your lab work, plus we reveal our most popular clinical interviews of the past year

Funding will support development of a Pseudomonas aeruginosa targeted therapeutic, to tackle the genetic cause of antibiotic resistance